Q2 2025 Holdings
Filed 2025-08-14 | 94 holdings | $151.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Lenz Therapeutics(LENZ) | COM | 52635N103 | $28.6M | 977,245 | 18.9% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $7.0M | 8,976 | 4.6% |
| Unitedhealth GRP Inc(UNH) | COM | 91324P102 | $5.2M | 16,745 | 3.4% |
| Mineralys Therapeuti(MLYS) | COM | 603170101 | $5.2M | 382,415 | 3.4% |
| Contineum Therapeuti(CTNM) | CL A | 21217B100 | $3.2M | 800,787 | 2.1% |
| Amgen Inc(AMGN) | COM | 031162100 | $3.1M | 11,270 | 2.1% |
| Vertex Pharma(VRTX) | COM | 92532F100 | $3.1M | 6,945 | 2.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $2.9M | 19,300 | 1.9% |
| Intuitive Surgic Inc(ISRG) | COM NEW | 46120E602 | $2.9M | 5,250 | 1.9% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $2.7M | 14,800 | 1.8% |
| Oric Pharmaceutica(ORIC) | COM | 68622P109 | $2.3M | 231,485 | 1.6% |
| Boston Scientific(BSX) | COM | 101137107 | $2.3M | 21,126 | 1.5% |
| Argenx SE SPN(ARGX) | SP ADR | 04016X101 | $2.3M | 4,085 | 1.5% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $2.2M | 191,825 | 1.4% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $2.2M | 19,690 | 1.4% |
| Palvella Therapeutic(PVLA) | COM | 697947109 | $2.2M | 95,615 | 1.4% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $2.2M | 231,650 | 1.4% |
| Arcus Biosciences(RCUS) | COM | 03969F109 | $2.1M | 257,270 | 1.4% |
| Danaher Corp(DHR) | COM | 235851102 | $2.1M | 10,575 | 1.4% |
| Abbott Labs(ABT) | COM | 002824100 | $2.1M | 15,198 | 1.4% |
| Solid Biosciences(SLDB) | COM NEW | 83422E204 | $2.1M | 421,580 | 1.4% |
| Rapport Therapeutics(RAPP) | COM | 75383L102 | $2.0M | 179,860 | 1.4% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $2.0M | 210,625 | 1.3% |
| Ventyx Biosciences(VTYX) | COM | 92332V107 | $2.0M | 931,620 | 1.3% |
| Tectonic Therapeutic(TECX) | COM | 878972108 | $2.0M | 98,970 | 1.3% |
| Bicara Therapeutics(BCAX) | COM | 055477103 | $1.9M | 201,395 | 1.2% |
| Pfizer Inc(PFE) | COM | 717081103 | $1.9M | 77,150 | 1.2% |
| Beone Medicines LTD(ONC) | SP ADR | 07725L102 | $1.9M | 7,716 | 1.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.9M | 323,572 | 1.2% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $1.9M | 116,510 | 1.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $1.9M | 83,900 | 1.2% |
| Instil BIO Inc(TIL) | COM NEW | 45783C200 | $1.8M | 86,220 | 1.2% |
| Immatics NV(IMTX) | SHS | N44445109 | $1.8M | 332,270 | 1.2% |
| Biontech SE(BNTX) | SP ADR | 09075V102 | $1.7M | 16,160 | 1.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $1.7M | 20,900 | 1.1% |
| Thermo Fisher SCI(TMO) | COM | 883556102 | $1.6M | 3,900 | 1.0% |
| Stryker Corp(SYK) | COM | 863667101 | $1.5M | 3,900 | 1.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.5M | 14,880 | 1.0% |
| Regeneron Pharmctcls(REGN) | COM | 75886F107 | $1.5M | 2,773 | 1.0% |
| Summit Therapeutics(SMMT) | COM | 86627T108 | $1.4M | 65,220 | 0.9% |
| Astrazeneca(AZN) | SP ADR | 046353108 | $1.3M | 18,640 | 0.9% |
| Biomarin Pharmac Inc(BMRN) | COM | 09061G101 | $1.3M | 23,530 | 0.9% |
| Edwards Lifescience(EW) | COM | 28176E108 | $1.2M | 15,000 | 0.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $1.2M | 13,200 | 0.8% |
| ARS Pharmaceuticals(SPRY) | COM | 82835W108 | $1.1M | 65,785 | 0.8% |
| Alnylam Pharmacuetcl(ALNY) | COM | 02043Q107 | $1.1M | 3,323 | 0.7% |
| Structure Therapeu(GPCR) | SP ADR | 86366E106 | $1.1M | 51,369 | 0.7% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $975.8K | 41,418 | 0.6% |
| Merus B V | COM | N5749R100 | $824.5K | 15,675 | 0.5% |
| Globus MED Inc(GMED) | CL A | 379577208 | $796.8K | 13,500 | 0.5% |